Search Results 231-240 of 18171 for creatine evidence

1. Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients with Refractory Advanced Solid Tumors - Mayo Clinic

   Histologic evidence of advanced solid tumors (excluding central nervous ... Creatinine less than 1.5 x UNL. Women of childbearing potential must have a ...

2. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Creatinine clearance of ≥ 30 ml/min (as ... Evidence of disease transformation at the time of study entry. ... evidence of CNS disease prior to study entry.

3. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

   Serum creatinine ≤ 1.5 x the ULN ... months before randomization, or myocardial infarction within 6 months before randomization. Evidence or history of bleeding ...

4. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   Creatinine ≤ 1.5 x upper limit of normal (ULN) OR measured or calculated creatinine ... evidence of progression by imaging using the identical imaging modality ...

5. A Study of the Safety and Effectiveness of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unremoveable Malignant Pleural Mesothelioma - Mayo Clinic

   Evidence of other active, invasive malignancy requiring treatment within the past 5 years. Noninvasive cancer history (such as carcinoma-in-situ [CIS] that ...

6. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

   Chronic kidney disease with serum creatinine ≥2.5 mg/dL. Active ... New findings about the temporal connection between AF and stroke, alongside evidence ...

7. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

   ... (creatinine clearance [CrCl] ≥ 60 mL/min); Group R3: Hepatic: normal ... evidence of cardiac dysfunction as determined by the investigator; Use of an ...

8. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

   ... evidence of liver metastasis, in which case the AST (SGOT)/ALT (SGPT) must be ≤ 5 times institutional upper limit of normal; Creatinine within normal ...

9. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

   ... evidence of graft versus host disease (GVHD). Autologous stem cell infusion ... Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min ...

10. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer - Mayo Clinic

    Screen labs of Hemoglobin,white blood cells, platelets, absolute neutrophil count (ANC), bilirubin, AST, ALT, serum creatinine ... Evidence of deep vein ...